14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study

      research-article
      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 1 , 2 , 9 , 1 , 10 , 11 , 12 , 13 , 13 , 14 , 15 , 1 , 2 , 16 , 17 , 18 , 19 , 16 , 1 , 13 , 20 , 21 , 1 , 2 , 9 , 1 , 2 , 9 ,
      Kidney International Reports
      Elsevier
      acute kidney injury, biomarker, diagnosis, sepsis

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Sepsis is the leading cause of acute kidney injury (AKI) in critically ill patients. The Kidney in Sepsis and Septic Shock (Kid-SSS) study evaluated the value of proenkephalin A 119-159 (penkid)—a sensitive biomarker of glomerular function, drawn within 24 hours upon intensive care unit (ICU) admission and analyzed using a chemiluminescence immunoassay—for kidney events in sepsis and septic shock.

          Methods

          The Kid-SSS study was a substudy of Adrenomedullin and Outcome in Severe Sepsis and Septic Shock (AdrenOSS) (NCT02393781), a prospective, observational, multinational study including 583 patients admitted to the intensive care unit with sepsis or septic shock and a validation cohort of 525 patients from the French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) study. The primary endpoint was major adverse kidney events (MAKEs) at day 7, composite of death, renal replacement therapy, and persistent renal dysfunction. The secondary endpoints included AKI, transient AKI, worsening renal function (WRF), and 28-day mortality.

          Results

          Median age was 66 years (interquartile range 55–75), and 28-day mortality was 22% (95% confidence interval [CI] 19%−25%). Of the patients, 293 (50.3%) were in shock upon ICU admission. Penkid was significantly elevated in patients with MAKEs, persistent AKI, and WRF (median = 65 [IQR = 45–106] vs. 179 [114–242]; 53 [39–70] vs. 133 [79–196] pmol/l; and 70 [47–121] vs. 174 [93–242] pmol/l, all P < 0.0001), also after adjustment for confounding factors (adjusted odds ratio = 3.3 [95% CI = 1.8–6.0], 3.9 [95% CI = 2.1–7.2], and 3.4 [95% CI = 1.9–6.2], all P < 0.0001). Penkid increase preceded elevation of serum creatinine with WRF and was low in renal recovery.

          Conclusion

          Admission penkid concentration was associated with MAKEs, AKI, and WRF in a timely manner in septic patients.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Recovery after Acute Kidney Injury.

          Little is known about how acute kidney injury (AKI) resolves, and whether patterns of reversal of renal dysfunction differ among patients with respect to ultimate recovery.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study

            Introduction The role of systemic hemodynamics in the pathogenesis of septic acute kidney injury (AKI) has received little attention. The purpose of this study was to investigate the association between systemic hemodynamics and new or persistent of AKI in severe sepsis. Methods A retrospective study between 2006 and 2010 was performed in a surgical ICU in a teaching hospital. AKI was defined as development (new AKI) or persistent AKI during the five days following admission based on the Acute Kidney Injury Network (AKIN) criteria. We studied the association between the following hemodynamic targets within 24 hours of admission and AKI: central venous pressure (CVP), cardiac output (CO), mean arterial pressure (MAP), diastolic arterial pressure (DAP), central venous oxygen saturation (ScvO2) or mixed venous oxygen saturation (SvO2). Results This study included 137 ICU septic patients. Of these, 69 had new or persistent AKI. AKI patients had a higher Simplified Acute Physiology Score (SAPS II) (57 (46 to 67) vs. 45 (33 to 52), P < 0.001) and higher mortality (38% vs. 15%, P = 0.003) than those with no AKI or improving AKI. MAP, ScvO2 and CO were not significantly different between groups. Patients with AKI had lower DAP and higher CVP (P = 0.0003). The CVP value was associated with the risk of developing new or persistent AKI even after adjustment for fluid balance and positive end-expiratory pressure (PEEP) level (OR = 1.22 (1.08 to 1.39), P = 0.002). A linear relationship between CVP and the risk of new or persistent AKI was observed. Conclusions We observed no association between most systemic hemodynamic parameters and AKI in septic patients. Association between elevated CVP and AKI suggests a role of venous congestion in the development of AKI. The paradigm that targeting high CVP may reduce occurrence of AKI should probably be revised. Furthermore, DAP should be considered as a potential important hemodynamic target for the kidney.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Subclinical AKI--an emerging syndrome with important consequences.

              According to guidelines published by Kidney Disease: Improving Global Outcomes, patients at risk of acute kidney injury (AKI) should be managed according to their susceptibilities and exposures. Clinical evaluation of a patient's risk of acute loss of renal function is of undisputed importance. However, such evaluations can be hindered by the complex presentations of critically ill patients and the lack of methods to detect early kidney damage. In this regard, a tool for diagnosis and stratification of patients at risk of AKI would complement clinical assessments and enable improved therapeutic decision-making. Emerging evidence suggests that 15-20% of patients who do not fulfil current serum-creatinine-based consensus criteria for AKI are nevertheless likely to have acute tubular damage, which is associated with adverse outcomes. This evidence supports reassessment of the concept and evolution of the definition of AKI to incorporate biomarkers of tubular damage.
                Bookmark

                Author and article information

                Contributors
                Journal
                Kidney Int Rep
                Kidney Int Rep
                Kidney International Reports
                Elsevier
                2468-0249
                22 August 2018
                November 2018
                22 August 2018
                : 3
                : 6
                : 1424-1433
                Affiliations
                [1 ]Department of Anaesthesiology, Burn and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals, Paris, France
                [2 ]INSERM 942, Paris, France
                [3 ]Department of Anesthesia, Surgical Intensive Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, Switzerland
                [4 ]Department of Critical Care Medicine, St Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium
                [5 ]Intensive Care Unit Department, CHU Dupuytren, Limoges, France
                [6 ]INSERM CIC 1435/UMR 1092, Limoges, France
                [7 ]Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, Netherlands
                [8 ]Fondazione Policlinico Universitario A. Gemelli, Rome, Italy
                [9 ]University Paris Diderot, Paris, France, and INI-CRCT (F-CRIN) network
                [10 ]Centre Hospitalier Universitaire de Nantes, Nantes, France
                [11 ]Clinique St Pierre, Ottignies, Belgium
                [12 ]Sant’ Andrea Hospital, Rome, Italy
                [13 ]Sphingotec GmbH, Hennigsdorf, Germany
                [14 ]Department of Intensive Care, Medisch Spectrum Twente, Enschede, Netherlands
                [15 ]Department of Perioperative Medicine, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France
                [16 ]Centre Hospitalier Universitair de Tours, Tours, France
                [17 ]Hôpital Louis Mourier, Colombes, France
                [18 ]Hôpital Jolimont, Haine-St-Paul, Belgium
                [19 ]Klinik für Operative Intensivmedizin und Intermediate Care, Universitätsklinikum der RWTH, Aachen, Germany
                [20 ]Hôpital Bichat Claude-Bernard, Paris, France
                [21 ]Department of Critical Care Medicine, Saint Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium
                Author notes
                [] Correspondence: Matthieu Legrand, Department of Anaesthesiology, Critical Care Medicine and Burn Unit, St-Louis Hospital, Assistance Publique−Hôpitaux de Paris, 1 Avenue Claude Vellefaux, 75010, Paris, France. matthieu.legrand@ 123456aphp.fr
                Article
                S2468-0249(18)30191-8
                10.1016/j.ekir.2018.08.006
                6224621
                30450469
                ac752b6d-e625-4806-bedb-e83e3aa2ca28
                © 2018 International Society of Nephrology. Published by Elsevier Inc.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 29 June 2018
                : 13 August 2018
                Categories
                Clinical Research

                acute kidney injury,biomarker,diagnosis,sepsis
                acute kidney injury, biomarker, diagnosis, sepsis

                Comments

                Comment on this article